AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18572868
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy of medication with local hyperthermia (CRS-2280E system, anal administration of 1 Qianliean suppository, oral doxazosin 4 mg before bedtime for 2 weeks)
Trial: 24228532
Drug: Xuezhikang capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xuezhikang capsule
Trial: 17933486
Drug: Buprenorphine/naloxone treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine/naloxone treatment
Trial: 8853530
Drug: High-dose chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose chemotherapy (HDC) as consolidation therapy
Trial: 2186651
Drug: diclofenac 75
RxNorm normalized name: CAPSAICIN 0.025%/DICLOFENAC 75MG KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diclofenac 75 mg intramuscularly
Trial: 2186651
Drug: nefopam 20
RxNorm normalized name: nefopam 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nefopam 20 mg intramuscularly
Trial: 2186651
Drug: oral paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oral paracetamol as required
Trial: 252699
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of ten units of regular insulin (U.S.P.) twice daily
Trial: 27734550
Drug: Percutaneous radiofrequency
RxNorm normalized name: PERCUTANEOUS INTRODUCER SET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percutaneous radiofrequency treatment applied to the ramus communicans
Trial: 27734550
Drug: Sham procedure
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Sham procedure (same procedure except radiofrequency treatment)
Trial: 16990660
Drug: Lowest birth
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lowest birth weight (<2500 g)
Trial: 15589067
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (10 mg sibutramine/d + 3 x 120 mg orlistat/d, n = 20)
Trial: 23885610
Drug: Rehabilitation therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rehabilitation therapy alone (group B)
Trial: 23885610
Drug: Acupuncture combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture combined with rehabilitation therapy (group A)
Trial: 16740370
Drug: Baclofen (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baclofen (20 mg tid)
Trial: 16740370
Drug: Gabapentin (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin (800 mg tid)
Trial: 29020373
Drug: Artemether-Lumefantrine (AL)
RxNorm normalized name: ARTEMETHER/LUMEFANTRINE
DrugBank: Lumefantrine co-artemether (DB13085)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artemether-Lumefantrine (AL) - total target dose: 12 mg/kg for artemether and 60 mg/kg for lumefantrine
Trial: 7863813
Drug: Low-dose IL-2
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose IL-2 (3 million IU/day for 6 days/week)
Trial: 7863813
Drug: Epirubicin (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epirubicin (25 mg/m2 i.v. weekly)
Trial: 2488472
Drug: Glucagon (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucagon (0.5 mg i.v. bolus followed by 1.5 mg infused over 90 minutes)
Trial: 23595161
Drug: CALM-BP treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CALM-BP treatment
Trial: 18652319
Drug: Routine comprehensive
RxNorm normalized name: Easy Care First Aid Kit - Comprehensive KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine comprehensive therapy and moxibustion at Zusanli (ST 36), Guanyuan (CV 4), Sanyinjiao (SP 6)
Trial: 18652319
Drug: Routine comprehensive
RxNorm normalized name: Easy Care First Aid Kit - Comprehensive KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine comprehensive therapy (including hemodialysis and medication)
Trial: 16950175
Drug: Niacin treatment
RxNorm normalized name: Niacin
DrugBank: Niacin (DB00627)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Niacin treatment for 3 months
Trial: 10766318
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy with amoxicillin, clarithromycin, pantoprazole
Trial: 10766318
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy with tinidazole, clarithromycin, ranitidine bismuth citrate
Trial: 10766318
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy with tinidazole, clarithromycin, pantoprazole
Trial: 10099862
Drug: Lamotrigine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamotrigine (100 mg/day)
Trial: 8823232
Drug: Lamotrigine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamotrigine (150 mg/day)
Trial: 8823232
Drug: Valproate (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valproate (500 mg Depakote twice a day)
Trial: 30206423
Drug: Robotic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Robotic therapy (RT) using the Armeo Power
Trial: 22409590
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg S-equol/day
Trial: 22409590
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg S-equol/day
Trial: 22409590
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg S-equol/day
Trial: 2179067
Drug: Acyclovir (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir (400 mg bid)
Trial: 26519710
Drug: 20% human
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20% human albumin (5 mL/kg)
Trial: 26519710
Drug: 0.9% saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% saline (5 mL/kg)
Trial: 10699609
Drug: Electrical stimulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electrical stimulation (10-hertz square waves of 1-ms pulse duration, vaginal electrode for women, anal or surface electrode for men) for 15 minutes twice daily for 4 weeks
Trial: 27404026
Drug: CE/BZA 0.45/20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CE/BZA 0.45/20 mg
Trial: 27404026
Drug: CE/BZA 0.625/20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CE/BZA 0.625/20 mg
Trial: 20537851
Drug: Nebulized morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized morphine administered every 30 minutes until the second hour, then every 4 hours for 48 hours
Trial: 20537851
Drug: Thoracic epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thoracic epidural analgesia with a mixture of 0.125% bupivacaine and 0.115% fentanyl continuously infused at 7 ml/h for 48 hours
Trial: 18504089
Drug: Analgesic Imagery
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Analgesic Imagery
Trial: 15503293
Drug: 6-thioguanine (TG)
DrugBank: Tioguanine (DB00352)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6-thioguanine (TG) at a targeted dose of 50 mg/m²/day during maintenance therapy
Trial: 22514211
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (3 g/day for 4 weeks)
Trial: 22514211
Drug: Olive oil
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olive oil (3 g/day for 4 weeks)
Trial: 19460770
Drug: G-CSF (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF (10 microg/kg/day) injection for 3 days after PCI in the AMI-G-CSF group.
Trial: 19460770
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no G-CSF treatment) in the OMI-control group.
Trial: 19460770
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no G-CSF treatment) in the healthy-control group.
Trial: 17526858
Drug: Enteric-coated mycophenolate
RxNorm normalized name: mycophenolic acid
DrugBank: Mycophenolic acid (DB01024)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enteric-coated mycophenolate (360 mg twice daily)
Trial: 15577621
Drug: Interleukin-2 therapy
RxNorm normalized name: Interleukin-2 aldesleukin
DrugBank: Aldesleukin (DB00041)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interleukin-2 therapy (9 x 10(6) IU/day for 4-5 days)
Trial: 9618617
Drug: 2 injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 injections of tetanus toxoid
Trial: 7999529
Drug: Oral magnesium
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral magnesium supplementation in ischaemic heart disease patients
Trial: 30335073
Drug: Phenazepam (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenazepam (1 mg)
Trial: 25387888
Drug: Prasugrel (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel (10 mg once daily for 15 days)
Trial: 22014970
Drug: Wound infiltration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wound infiltration with 0.5% bupivacaine and i.m. 75 mg diclofenac (group BD)
Trial: 19164830
Drug: Oral quercetin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral quercetin (250 mg, 4x/day; 1,000 mg/day total)
Trial: 19164830
Drug: Quercetin-free supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quercetin-free supplements
Trial: 19164830
Drug: Oral quercetin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral quercetin
Trial: 11463999
Drug: Intensified dietary
RxNorm normalized name: sodium phosphate, monobasic
DrugBank: Sodium phosphate, monobasic (DB09449)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensified dietary counselling, ready-made liquid nutritional supplements free of charge, regular follow-ups
Trial: 9923569
Drug: Mibefradil (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mibefradil (50 mg)
Trial: 10442205
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg tramadol
Trial: 3057512
Drug: 1,000 mg
RxNorm normalized name: bran 1,000 mg ORAL WAFER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,000 mg metamizole
Trial: 3057512
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg metamizole
Trial: 19797985
Drug: Aripiprazole 5
RxNorm normalized name: aripiprazole 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aripiprazole 5 mg/day
Trial: 29774635
Drug: Aripiprazole 2
RxNorm normalized name: aripiprazole 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aripiprazole 2 mg/day
Trial: 15770435
Drug: Cholesterol-lowering medication
RxNorm normalized name: Cholesterol
DrugBank: Cholesterol (DB04540)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholesterol-lowering medication adherence
Trial: 9032500
Drug: Dirithromycin, 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dirithromycin, 500 mg orally once daily for five consecutive days
Trial: 9032500
Drug: Erythromycin base,
RxNorm normalized name: Erythromycin Base, 500 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin base, 1000 mg orally four times daily for seven days
Trial: 29143534
Drug: Lithium-based treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lithium-based treatment
Trial: 17409909
Drug: Pemetrexed plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pemetrexed plus cisplatin (500 mg/m pemetrexed + 75 mg/m cisplatin)
Trial: 1622858
Drug: Immediate surgery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate surgery without neoadjuvant chemotherapy
Trial: 6147454
Drug: H2-receptor antagonist
RxNorm normalized name: H2-receptor antagonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H2-receptor antagonist ranitidine (150 mg)
Trial: 6147454
Drug: H1-receptor antagonist
RxNorm normalized name: Interleukin-1 receptor antagonist anakinra
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: H1-receptor antagonist terfenadine (60 mg)
Trial: 27039928
Drug: Positive Airway
RxNorm normalized name: VersaPAP Positive Airway Pressure Device
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Positive Airway Pressure (PAP) therapy
Trial: 20432816
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose isoflavone (16 mg)
Trial: 15063404
Drug: Inhaled fluticasone
RxNorm normalized name: fluticasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled fluticasone propionate (FP), 750 microg, twice/day for 3 months
Trial: 14555565
Drug: Inhaled fluticasone
RxNorm normalized name: fluticasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled fluticasone propionate (FP)
Trial: 12564092
Drug: 0.5% trimecain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% trimecain infiltration into the thyroid capsule (n = 32)
Trial: 12564092
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group with saline infiltration into the thyroid capsule (n = 32)
Trial: 21103664
Drug: Iloprost infusion
RxNorm normalized name: Iloprost
DrugBank: Iloprost (DB01088)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iloprost infusion for one week
Trial: 16750985
Drug: Baseline bronchodilator
RxNorm normalized name: Bronchodil
DrugBank: Reproterol (DB12846)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline bronchodilator response
Trial: 11081782
Drug: Conventional antihypertensive
RxNorm normalized name: ANTIHYPERTENSIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional antihypertensive drugs (diuretics or beta-blockers)
Trial: 2860336
Drug: Fenoterol (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoterol (0.2 mg/puff, 3 times 2 puffs)
Trial: 2860336
Drug: Fenoterol (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoterol (0.2 mg/puff, 3 times 3 puffs)
Trial: 2860336
Drug: Fenoterol (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoterol (0.2 mg/puff, 3 times 4 puffs)
Trial: 24375206
Drug: LAI risperidone
RxNorm normalized name: Risperidone
DrugBank: Risperidone (DB00734)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: LAI risperidone 12.5 to 50 mg per injection biweekly
Trial: 24375206
Drug: Psychiatrist's choice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychiatrist's choice of oral antipsychotics
Trial: 9660108
Drug: Lamotrigine (LTG)
RxNorm normalized name: Lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lamotrigine (LTG) 300 mg/day
Trial: 2551397
Drug: Intravenous 2-deoxy-D-glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous 2-deoxy-D-glucose (2DG) administration
Trial: 11551575
Drug: Oral immune‐enhancing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral immune‐enhancing nutritional supplement (n=25)
Trial: 8330828
Drug: 2.4 mg
RxNorm normalized name: pectin 2.4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.4 mg glycerol trinitrate (GTN) administered in various forms (2 x 1.2 mg capsules; 6 x 0.4 mg puffs of an atomizer; 2.4 ml of an 0.1% infusion solution)
Trial: 6101174
Drug: Propranolol (240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (240 mg daily for two weeks)
Trial: 16827683
Drug: Tacrolimus-based therapy
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tacrolimus-based therapy (n = 33)
Trial: 16827683
Drug: Cyclosporine microemulsion-based
RxNorm normalized name: cyclosporine microemulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine microemulsion-based therapy (n = 33)
Trial: 8689806
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg buprenorphine and 2 mg naloxone combined
Trial: 25792802
Drug: Transdermal donepezil
RxNorm normalized name: donepezil Transdermal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal donepezil patch
Trial: 23506277
Drug: 127.2 mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 127.2 mg lidocaine with 50 μg epinephrine plus 0.5 M mannitol (5 mL formulation)
Trial: 23506277
Drug: 127.2 mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 127.2 mg lidocaine with 50 μg epinephrine (3.18 mL formulation)
Trial: 21455087
Drug: Hydrocortisone (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone (100 mg) given at 2 doses 8 hrs apart
Trial: 9173967
Drug: Hydrocortisone (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone (100 mg)
Trial: 19653988
Drug: STD-14 (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: STD-14 (0.25 mg/kg/day for 14 days)
Trial: 19653988
Drug: STD-3 (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: STD-3 (0.25 mg/kg/day for 3 days)
Trial: 3891378
Drug: Slow-release furosemide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow-release furosemide 30 mg daily
Trial: 31780018
Drug: Craniosacral Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Craniosacral Therapy (CST)
Trial: 22901362
Drug: Olanzapine (5-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine (5-20 mg/d; mean dose = 13.5 mg/d)
Trial: 22901362
Drug: Lithium (300-1,800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lithium (300-1,800 mg/d; mean dose = 1,003.3 mg/d)
Trial: 15910516
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg melatonin administered at 18:00 or 19:00 hours
Trial: 15910516
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered at 18:00 or 19:00 hours
Trial: 9517367
Drug: Single oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single oral dose of carbamazepine (200-800 mg)
Trial: 9517367
Drug: Multiple dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple dosing of carbamazepine (400-800 mg twice daily for 14 days)
Trial: 8038904
Drug: Sodium valproate
RxNorm normalized name: sodium valproate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium valproate (600 mg in three divided doses orally)
Trial: 8038904
Drug: Naloxone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (10 mg as an iv bolus injection)
Trial: 7762325
Drug: Suppressive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suppressive therapy
Trial: 31012853
Drug: PFT-guided de-escalation
RxNorm normalized name: sangre de grado
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PFT-guided de-escalation of dual antiplatelet therapy (DAPT)
Trial: 29912422
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment with prasugrel for 12 months (control group)
Trial: 21962461
Drug: Group treatment
RxNorm normalized name: Allergenic Extracts Intradermal Kit [9 SO. GRASS GROUP TREATMENT SET]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group treatment sessions (GT) of pelvic floor muscle training (PFMT) for 6 weeks, with two 1-hour sessions per week.
Trial: 17360209
Drug: Nebulized albuterol
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized albuterol (2.5mg)
Trial: 10673512
Drug: IM862 intranasal
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IM862 intranasal drops at a dose of 5 mg, given in two dosing schedules: 5 days on, 5 days off (n = 18)
Trial: 10673512
Drug: IM862 intranasal
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IM862 intranasal drops at a dose of 5 mg, given every other day (n = 26)
Trial: 1993279
Drug: Ethoglucid (0.565
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethoglucid (0.565 g, 1% solution) weekly for 6 weeks, then monthly for 1 year
Trial: 1993279
Drug: Keyhole-limpet haemocyanin
RxNorm normalized name: Keyhole limpet hemocyanin
DrugBank: Keyhole limpet hemocyanin (DB05299)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Keyhole-limpet haemocyanin (KLH) 1 mg subcutaneously, followed by bladder instillations of 30 mg weekly for 6 weeks, then monthly for 1 year
Trial: 6394516
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg captopril
Trial: 7033946
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg indapamide
Trial: 29143355
Drug: Oral appliances
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral appliances with an occlusal flat table
Trial: 26964901
Drug: 30 mg/mL
RxNorm normalized name: urea 30 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg/mL ketorolac buccal infiltration
Trial: 24627629
Drug: No Treatment
RxNorm normalized name: NO
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No Treatment
Trial: 19675960
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy plus Motivational Interviewing (CBT + MI)
Trial: 19675960
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy plus Psychoeducation (CBT + PE)